U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
NOTIFICATION OF LATE FILING
FORM 12b-25
SEC File Number 0-15266 Cusip Number 09057G 60 2
------- -----------
(Check One)
Form 10-K Form 20-F Form 11-K X Form 10-Q Form N-SAR
- ---- ---- ---- ----- ----
For the Period Ended: January 31, 1999
----------------
( ) Transition Report on Form 10-K
( ) Transition Report on Form 20-F
( ) Transition Report on Form 11-K
( ) Transition Report on Form 10-Q
( ) Transition Report on Form N-SAR
For the Transition Period Ended
---------------------
Read Instructions (on back page) Before Preparing Form
Please Print or Type
Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein
If the notification relates to a portion of the filing checked above, identify
the Item(s) to which the notification relates:
-----------------------------------------------------------------------------
- --------------------------------------------------------------------------------
PART I. REGISTRANT INFORMATION
- --------------------------------------------------------------------------------
Full Name of Registrant: BIO-REFERENCE LABORATORIES, INC.
- -------------------------------------------------------------------------------
Former Name if Applicable:
- --------------------------------------------------------------------------------
Address of Principal Executive Office (Street and Number):
481 EDWARD H. ROSS DRIVE
- --------------------------------------------------------------------------------
City, State and Zip Code:
ELMWOOD PARK, NEW JERSEY 07407
- --------------------------------------------------------------------------------
PART II - RULES 12b-25(b) and (c)
- --------------------------------------------------------------------------------
If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed.
(Check box if appropriate)
(a) The reasons described in reasonable detail in Part III of this
form could not be eliminated without unreasonable effort or
expenses;
(x) (b) The subject annual report, semi-annual report, transition report
on Form 10-K, form 2-F, Form 11-K, Form N-SAR, or portion
thereof, will be filed on or before the fifteenth calendar day
following the prescribed due date; or the subject quarterly
report or transition report on Form 10-Q, or portion thereof will
be filed on or before the fifth calendar day following the
prescribed due date; and
(c) The accountant's statement or other exhibit required by Rule 12b-
25(c) has been attached if applicable.
- --------------------------------------------------------------------------------
PART III - NARRATIVE
- --------------------------------------------------------------------------------
State below in reasonable detail the reasons why the Form 10-K, 20-F, 11-K, 10-Q
or N-SAR, or the transition report on portion thereof, could not be filed within
the prescribed time period. As a result of a recent acquisition,the Company has
not been able to compile the requisite financial data necessary to enable it to
have sufficient time to complete the Company's financial statements by March 17,
1998, which is the required filing date for the Company's quarterly report on
Form 10-Q, without unreasonable effort and expense.
- --------------------------------------------------------------------------------
PART IV - OTHER INFORMATION
- --------------------------------------------------------------------------------
(1) Name and telephone number of person to contact in regard to this
notification.
Sam Singer 201 791-2600
---------- ----------- --------------
(Name) (Area Code) (Telephone No.)
(2) Have all other periodic reports required under Section 13 or 159d) of
the Securities and Exchange Act of 1934 or Section 30 of the
Investment Company Act of 1940 during the preceding 12 months (or for
such shorter period that the registrant was required to file such
reports) been filed? If answer is no, identify report(s)
(x) Yes ( ) No
(3) Is it anticipated that any significant change in results of operations
from the corresponding period for the last fiscal year will be
reflected by the earning statements to be included in the subject
report or portion thereof?
(x) Yes ( ) No
If so, attach an explanation of the anticipated change, both
narratively and quantitatively, and, if appropriate, state the reasons
why a reasonable estimate of the results cannot be made.
The Company anticipates a net loss of approximately $110,000 resulting
from income from operations of approximately $210,000 and other
expenses of approximately $320,000.
- --------------------------------------------------------------------------------
BIO-REFERENCE LABORATORIES, INC.
--------------------------------
(Name of Registrant as Specified in Charter)
has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.
Date: March 17, 1999 By: Sam Singer
-------------- ----------
Sam Singer, Vice President
INSTRUCTION: The form may be signed by an executive officer of the registrant or
by any other duly authorized representative. The name and title of the person
signing the form shall be typed or printed beneath the signature. if the
statement is signed on behalf of the registrant by an authorized representative
(other than an executibve officer), evidence of the representative's authority
to sign on behalf of the registrant shall be filed with the form.
ATTENTION
Intentional misstatements or omissions of fact constitute
Federal Criminal Violation (See 18 U.S.C. 1001)
GENERAL INSTRUCTIONS
1. This form is required by Rule 12b-25 (17 CFR 250.12b-25) of the General
Rules and Regulations under the Securities Exchange Act of 1934.
2. One signed original and four conformed copies of this form and amendments
thereto must be completed and filed with the Securities and Exchange
Commission, Washington, D.C. 20549, in accordance with Rule 0-3 of the
General Rules and Regulations under the Act. The information contained in
or filed with the form will be made a matter of public record in the
Commission files.
3. A manually signed copy of the form and amendments thereto shall be filed
with each national securities
4. Amendments to the notifications must also be filed on form 12b-25, but need
not restate information that has been correctly furnished. the form shall
be clearly identified as an amendment notification.
5. electronic filers - This form shall not be used by electronic filers unable
to timely file a report solely due to electronic difficulties. Files unable
to submit a report within the time period prescribed due to difficulties in
electronic filing should comply with either Rule 201 or Rule 202 of
Regulation S-T or apply for an adjustment in filing date pursuant to Rule
13(b) or Regulation S-T. J:\WP50\1319912B.EDG
